Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.Lilly...
Pharmaceuticals
Trump nominates Erica Schwartz as CDC director
A sign sits outside of the Centers for Disease Control and Prevention (CDC) Roybal campus in Atlanta, Georgia, U.S. March...
Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
After years of trying to lose weight "the right way," Jane Zuckerman realized that "putting in the work just wasn't...
Trump tariff fallout: Some industries grapple with lingering effects one year later
A year after President Donald Trump declared his "liberation day" and imposed sweeping tariffs on imports, kicking off a wave...
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Texas, Sept. 23, 2025.Antranik Tavitian |...
Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss
A tick (Ixodida) - carrier for several diseases of humans and animals, for exampel the dangerous Lyme disease, babesiosis, anaplasmosis,...
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients,...
Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the U.S., targeting...
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,...
With Trump's 'reciprocal' tariffs struck down, here are the industries still facing higher rates
The Supreme Court during a rain storm in Washington, Feb. 20, 2026.Annabelle Gordon | Bloomberg | Getty ImagesThe Supreme Court...
US signals crackdown on compounded weight-loss drugs; Hims shares tumble
The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims & Hers for its $49 weight-loss...
AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovation
Pharma giant AstraZeneca will list on the New York Stock Exchange on Monday, days after it announced big commitments on...
Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite
Drugmakers Roche and Sanofi's latest earnings were largely as expected, with the companies talking up the potential of experimental medicines...
Trump says tariffs on South Korean autos, pharma, to rise to 25% over trade deal approval delay
U.S. President Donald Trump speaks at the 2025 Asia-Pacific Economic Cooperation (APEC) CEO Summit in Gyeongju, South Korea, October 29,...
Novartis could have a U.S. deal that shields it from tariffs, CEO tells CNBC
Swiss pharmaceutical giant Novartis' CEO has said he "thinks" the company has an agreement with the U.S. to shield it...
Novo Nordisk enters 2026 on the defense as it faces a ‘must-win’ battle in the U.S. market
Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by: Michael Siluk/UCG/Universal Images...
Novo Nordisk's 'long game' on weight loss drugs sparks hope in science, but the Street is impatient
Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood sugar. (Photo...
Nine of the largest pharma companies ink deals with Trump to lower drug prices
US President Donald Trump during an announcement in the Roosevelt Room of the White House in Washington, DC, US, on...
Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs
Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025....
Metsera accepts Pfizer's $10 billion bid in ongoing M&A battle
Smith Collection | Archive Photos | Getty ImagesObesity drug developer Metsera said on Friday that it had accepted Pfizer's $10...
